Published on:

FDA states that pharmaceutical plant falsified generic drug data

CNN released today that the FDA has said that an India pharmaceutical plant falsified generic drug data. It has stopped reviewing drug applications from the plant because some of the falsified data has already resulted in approvals from the FDA.

To read more about the falsified drug data.